During the past decade, Centre Jean Perrin; Hopital De Semaine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Jean Perrin; Hopital De Semaine" are "Breast Cancer" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centre Jean Perrin; Hopital De Semaine" in a lesser frequency.

Most popular intervention types in "Centre Jean Perrin; Hopital De Semaine" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (1 trials), "Placebo" (1 trials) and "Taselisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Jean Perrin; Hopital De Semaine" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Jean Perrin; Hopital De Semaine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre Jean Perrin; Hopital De Semaine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Jean Perrin; Hopital De Semaine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".